Anpath Group, Inc. Announces Initial Production at New Manufacturing Facility
September 27 2007 - 8:30AM
PR Newswire (US)
MOORESVILLE, N.C., Sept. 27 /PRNewswire-FirstCall/ -- Anpath Group
Inc. (OTC:ANPG) (BULLETIN BOARD: ANPG) , reported today that its
wholly-owned subsidiary, EnviroSystems, Inc. (ESI) announced
completion of the initial production run by its manufacturing
partner, Minntech Corporation. The Company previously announced
that ESI had entered into a manufacturing agreement whereby
Minntech will be the exclusive manufacturer of ESI disinfectant
products. To support the arrangement, Minntech expanded its
manufacturing facility and established a dedicated production area
for EnviroSystems products. The Company stated that initial
production quantities of its new disinfectants EnviroTru(TM) and
EnviroTru(TM) 1453 would be shipped immediately to fill its order
backlog for these two products. "The ESI and Minntech team has
worked hard to reach this milestone and it is a critical step in
the continuing development of our company", stated J. Lloyd
Breedlove, ESI President & CEO. Mr. Breedlove continued, "The
transition of our manufacturing to Minntech insures our customers
of the highest possible product quality, guarantees our
distribution network that we have the capacity to meet future
growth and expansion, and frees important and valuable company
resources to focus on other aspects of our long-term strategic
plan. However, when all the advantages are considered, the ongoing
quality of our products is paramount. While our arrangement with
Minntech provides EnviroSystems with a world-class partner and may
offer other future synergistic business opportunities, the most
appealing aspect of this relationship is Minntech's unwavering
commitment to quality." Minntech Corporation, a subsidiary of
Cantel Medical Corp. (NYSE:CMN) located outside of Minneapolis, MN,
is an EPA and FDA registered facility. Minntech produces and sells
a wide range of infection prevention and control products in the
healthcare market, including specialized medical device
reprocessing systems for renal dialysis and endoscopy, as well as
disinfectants and sterilants. About Anpath Group, Incorporated:
Anpath Group, Inc., through its wholly-owned subsidiary
EnviroSystems, Inc., produces cleaning and disinfecting products
that it believes will help prevent the spread of infectious
microorganisms while minimizing the harmful effects to people,
equipment or the environment. EnviroSystems, Inc. is focused on
safe infection prevention technologies that the company believes
will position the company in the forefront of the industry at a
time when there is rapidly growing awareness of the critical need
to prevent biological risks -- both natural and man-made. Forward
Looking Statements: This release contains forward-looking
statements, which reflect expectation or belief by Anpath Group,
Inc. concerning future events that involve risks and uncertainties.
Anpath Group can give no assurance that the expectations reflected
in forward looking statements will prove correct and various
factors could cause results to differ materially from Anpath Group
expectations, including, but not limited to EPA registration of the
Company's products, the Company's ability to carry out its business
plan, successful development and commercial acceptance of its
products, ability to fund development of its technology, the risk
that products may not result from development activities,
protection of its intellectual property, need for regulatory
approvals, and other factors discussed in periodic Anpath Group,
Inc. filings with the Securities and Exchange Commission.
Forward-looking statements are qualified in their entirety by the
above cautionary statement. Anpath Group assumes no duty to update
its outlook or other forward-looking statements as of any future
date. DATASOURCE: Anpath Group, Inc. CONTACT: J. Lloyd Breedlove,
President & CEO of Anpath Group, Inc., +1-704-658-3350, Web
site: http://www.anpathgroup.com/
Copyright
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024